General Vascular Access Ic
Payments companies reported to CMS as associated with General Vascular Access Ic. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with General Vascular Access Ic, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with General Vascular Access Ic
These are the largest totals companies reported as associated with General Vascular Access Ic. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Milan Ravishankar | Las Vegas, NV | Cardiovascular Disease | $1,522.08 |
| Amr Marawan | Plano, TX | Cardiovascular Disease | $159.71 |
| Parth Patel | Boston, MA | Cardiovascular Disease | $159.71 |
| Matthew Langston | Lancaster, PA | Interventional Cardiology | $159.71 |
| Olivia Hulme | Boston, MA | Cardiovascular Disease | $159.71 |
| Nihar Jena | Pontiac, MI | Cardiovascular Disease | $159.71 |
| Agastya Belur | New Haven, CT | $159.71 | |
| Monika Karki | Fort Lauderdale, FL | Internal Medicine | $159.71 |
| Nicole Chahine | Youngstown, OH | Interventional Cardiology | $89.35 |
| Stefanos Votsis | Augusta, GA | $89.35 |
Prescribed General Vascular Access Ic?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.